ArticleFrontiers in pharmacology2026

Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway.

Zheng Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.